Reuters logo
7 months ago
BRIEF-Staidson Beijing Biopharmaceuticals sees 2016 net profit up 10 pct to 30 pct
January 11, 2017 / 6:42 AM / 7 months ago

BRIEF-Staidson Beijing Biopharmaceuticals sees 2016 net profit up 10 pct to 30 pct

Jan 11 (Reuters) - Staidson Beijing Biopharmaceuticals :

* Sees net profit for 2016 up 10 percent to 30 percent, or to be 232.2 million yuan to 274.4 million yuan

* Says the net profit of 2015 was 211.1 million yuan

Source text in Chinese: goo.gl/Ar44ou

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below